
|Articles|June 15, 2022
Daily Medication Pearl: Pregabalin (Lyrica)
Author(s)Saro Arakelians, PharmD
Lyrica is indicated for neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, spinal cord injury nerve pain, and pain after shingles in adult patients.
Advertisement
Medication Pearl of the Day: Pregabalin (Lyrica)
Indication: Lyrica is indicated for neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, spinal cord injury nerve pain, and pain after shingles in adult patients.
Insight:
- Dosing: For adult indications, begin dosing at 150 mg/day.
- Dosage forms: Capsules 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. Oral solution 20 mg/ mL.
- Adverse events: Most common adverse reactions (greater than or equal to 5% and twice placebo) in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and thinking abnormal (primarily difficulty with concentration/attention).
- Mechanism of action: Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues.
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
3
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
4
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
5

















































































































































































































